Evaxion A (EVAX) Current Leases (2019 - 2025)
Evaxion A's (EVAX) quarterly Current Leases came in at $360000.0 in Q4 2025, up 14.65% YoY from $314000.0 in Q4 2024, and up 1.12% on a QoQ basis from $356000.0 in Q2 2025.
Evaxion A (EVAX) Current Leases (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Current Leases data on file, last reported at $360000.0 in Q4 2025.
- Quarterly Current Leases rose 14.65% year-over-year to $360000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $360000.0 (up 14.65% YoY) and the FY2025 annual result came in at $360000.0, up 14.65% from the prior year.
- Current Leases advanced to $360000.0 in Q4 2025, from $356000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.3 million in Q3 2021 to a low of $292000.0 in Q2 2022.
- A 5-year average of $579000.0 and a median of $319000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases jumped 1470.0% — and 2022, when it plunged 70.47%.
- Tracing EVAX's Current Leases over 5 years: stood at $314000.0 in 2021, then slipped by 3.5% to $303000.0 in 2022, then climbed by 7.59% to $326000.0 in 2023, then declined by 3.68% to $314000.0 in 2024, then climbed by 14.65% to $360000.0 in 2025.
- The last three Current Leases figures came in at $360000.0 (Q4 2025), $356000.0 (Q2 2025), and $314000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Evaxion A | 27.86 Mn | 27.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Dec 31, 2022 | 303,000.00 |
| Jun 30, 2022 | 292,000.00 |
| Mar 31, 2022 | 311,000.00 |
| Dec 31, 2021 | 314,000.00 |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 974,000.00 |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 36,000.00 |